Contract development and manufacturing specialist Fortrea struck a partnership with Prague‑based SCTbio to provide combined clinical study support and production services for cell and gene therapy developers. The deal creates an end‑to‑end offering that bundles early clinical logistics with GMP manufacturing capacity, aiming to reduce handoffs that slow CGT programs. The tie‑up responds to ongoing industry demand for integrated CDMO services as sponsors seek faster translation from bench to first‑in‑human studies.